Sphaera Pharma Research And Development Private Limited - Company overview

Sphaerapharma is an active private limited company registered with ROC Delhi on 28 November 2008, about 17 years ago.

2008-11-28 New Delhi, Delhi Active Unlisted Active Compliant
Connect MCP

Key Metrics Public MCA facts are exact. Revenue, profit, assets, and employee figures may show as ranges until unlocked.

REVENUE
₹1–10 Lakh
▼ -64.8%
FY 2023
PROFIT / LOSS
Loss · ₹1–5 Cr
▼ -18370.6%
FY 2023
EBITDA
Under ₹1 Lakh
▼ -75.2%
FY 2023
NET WORTH
Loss · ₹1–5 Cr
▼ -41.2%
FY 2023
TOTAL ASSETS
₹10–50 Lakh
▼ -88.1%
FY 2023
OPEN CHARGES
1
-
PAID-UP CAPITAL
1.95 Lakh
AUTHORISED CAPITAL
5.00 Lakh
COMPANY AGE
17 Years 10 Months
since 2008-11-28
LAST FILING WITH ROC
2025-03-31
Last AGM: 2025-09-26
ACTIVE GST
1
Updated: 2025-05-30 01:03:40
TOTAL MONEY RAISED
Under ₹1 Lakh
SATISFIED CHARGES
1
1.19 cr

Company Health Scores Scores from 0–100 based on filings, compliance signals, financials, and board history on this profile.

Health scores for Sphaerapharma covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.

Vendor Trust Score Moderate
65/100
Overall counterparty comfort for vendors and customers.
  • Blend of compliance (88), financial health (5), director (95) and company-foundation signals.
  • Operating for 17+ years.
Compliance Score Low risk
88/100
Statutory filings, status and regulatory flags.
  • Company status is Active as per MCA.
  • Last balance sheet filed for Mar 2025 - slightly behind.
Financial Health Score High risk
5/100
Profitability, leverage and liquidity from filed statements.
  • Loss-making in FY 2023.
  • Negative net worth - capital eroded by losses.
Director Risk Score Low risk
95/100
Board strength, DIN status and churn.
  • 2 directors on the board.
  • No disqualified or deactivated DINs on the current board.
Scores are derived from MCA filings, financial statements and public records on this page. Higher is safer. They are indicative, not a credit rating.
360° Intelligence Report: trust score, financial health, credit risk, growth & distress signals - auto-generated from filings. View report →

About Sphaerapharma Company identity, industry, contact, and registration details from MCA and company records.

Sphaerapharma is an active private limited company registered with ROC Delhi on 28 November 2008, about 17 years ago. Its registered office is at A-5/110, Indra Enclave, Neb Sarai, New Delhi, Delhi.

Its filings describe the main line of business as scientific research and development, which made up 100% of turnover.

It has two directors: Abhinav Dhandia and Ashish Dugar. The longest-serving is Abhinav Dhandia, on the board since 2013; the most recent to join is Ashish Dugar, appointed in December 2022. Eight former directors are on record; the most recent to leave was Somdutta Sen in October 2021. Between them, the directors also sit on the boards of 8 other companies, including Cyro Healthcare Private Limited and Sphaera Pharma Private Limited.

Paid-up capital stands at ₹1.95 lakh out of ₹5 lakh authorised. The last AGM on record was on 26 September 2025, for accounts made up to 31 March 2025. The one charge registered against it has been satisfied, so no secured loan is open.

Pharma ••••••••
  • Location A-5/110, Indra Enclave, Neb Sarai,, New Delhi, Delhi - 110068
  • Website sphaerapharma.com
LinkedIn
Legal NameSphaera Pharma Research And Development Private Limited
CIN / LLPINU24232DL2008PTC224719
Company No.224719
ClassificationPrivate Limited Indian Non-Government Company
Incorporation Date2008-11-28
Date of AGM2025-09-26
Date of Balance Sheet2025-03-31
Listing StatusUnlisted
ROC CodeRoc Delhi
PAN
LEI Number
Active ComplianceActive Compliant

Current Directors of Sphaerapharma (2) Current board members from MCA filings, including designation and appointment details.

A
Abhinav Dhandia
Director | Since 2013-01-08 | DIN: 00456720
A
Ashish Dugar
Director | Since 2022-12-02 | DIN: 09810264

Financial Performance of Sphaerapharma Bands and Low / Medium / High trend shape. Exact figures unlock with your report.

Estimated bands · FY 2023
Revenue ₹1–10 Lakh ▼ -64.8%
P&L Loss · ₹1–5 Cr ▼ -18370.6%
EBITDA Under ₹1 Lakh ▼ -75.2%
Net worth Loss · ₹1–5 Cr ▼ -41.2%

Exact figures and labelled charts require an active report plan.

Verified entity values are shown only after access is granted.

Charges of Sphaerapharma Open and satisfied charges registered against the company with MCA.

Biotechnology Industry Research Assistance Council : 1.19 cr
Open Charges: 1 Satisfied Charges: 1
Open -
Satisfied 1.19 cr
LenderAmountStatus
Biotechnology Industry Research Assistance Council
Creation Date: 16 Dec 2011
 1.19 cr Closed

Business Activity Principal business activity and turnover mix from MCA filings.

Activity GroupDescriptionTurnover %
Professional, Scientific and TechnicalScientific research and development100

Companies With Common Directors Of Sphaerapharma Other companies that share directors with this entity, based on MCA and compliance network data.

Board Overlap From MCA / Compliance Filings

Cyro Healthcare Private Limited 2 Shared Directors
Sphaera Pharma Private Limited 2 Shared Directors
Advantium Infrastructure Private Limited 1 Shared Director
Dhandia Jewellers Llp 1 Shared Director
Jempore Solutions Private Limited 1 Shared Director
Muskan Greens And Emu Farms Private Limited 1 Shared Director
Sanctai Technology Private Limited 1 Shared Director
Sterling Green Homes Private Limited 1 Shared Director

Financial Ratios of Sphaerapharma Profitability, leverage, and liquidity ratios from filed statements. Exact values unlock with your report.

9 years of ratios on record

Profitability, leverage and liquidity ratios require an active report plan.

Net profit margin Debt / Equity Current ratio ROE

Unlock exact ratio values and multi-year insights.

Verified entity values are shown only after access is granted.

Shareholding Pattern of Sphaerapharma Ownership and contribution detail from filings. Full breakdown unlocks with your report.

8 shareholder categories on record

Ownership mix and contribution history require an active report plan.

Ownership mix Category breakdown Year-wise pattern Promoter holding

Unlock full ownership and contribution details.

Verified entity values are shown only after access is granted.

GST Compliance of Sphaerapharma GST registrations and filing status by state. Full compliance detail unlocks with your report.

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

GSTIN registrations State-wise filing status HSN and SAC details Tax jurisdiction records

GST registrations and filing compliance require an active report plan.

Verified entity values are shown only after access is granted.

MSME Payment Delays by Sphaerapharma MSME supplier payment delays and filing history. Full amounts unlock with your report.

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

Outstanding amounts Delay periods and reasons MSME-1 filing history Vendor payment signals

MSME payment history requires an active report plan.

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Sphaerapharma Official MCA forms, returns, and filing index. Document access unlocks with your report.

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

Incorporation documents Annual returns and statements Charge filings Complete filing index

MCA filings and documents require an active report plan.

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sphaerapharma Common questions about this company from MCA and profile data. Some answers are limited until unlocked.
Who is the owner of Sphaerapharma?
MCA does not publish an "owner" field. Sphaerapharma is run by its directors, Abhinav Dhandia and Ashish Dugar. The people who own the shares are listed in its annual return (form MGT-7), which can differ from the directors.
Who are the current board members and directors of Sphaerapharma?
Sphaerapharma has two current directors: Abhinav Dhandia (since January 2013) and Ashish Dugar (since December 2022).
What is CIN of Sphaerapharma?
The CIN of Sphaerapharma is U24232DL2008PTC224719. Reading it left to right: U means it is not listed, 24232 is the industry code it registered under, DL is Delhi, 2008 is the year it was registered, PTC is the company type and 224719 is its registration number.
When was Sphaerapharma incorporated?
Sphaerapharma was incorporated on 28 November 2008 with ROC Delhi. That makes it about 17 years old.
What is the registered address of Sphaerapharma?
The registered office on MCA records is A-5/110, Indra Enclave, Neb Sarai, New Delhi, Delhi - 110068.
What is the current status of Sphaerapharma?
MCA shows Sphaerapharma as Active, and its last AGM on record was in September 2025.
What is the contact number or email for Sphaerapharma?
You can post to its registered office at A-5/110, Indra Enclave, Neb Sarai, New Delhi, Delhi - 110068 and use its website, https://sphaerapharma.com.
What industry or business activity is Sphaerapharma associated with?
Its MCA filings list the main business as scientific research and development (100% of turnover).
What is paid-up capital and authorised share capital of Sphaerapharma?
Paid-up capital is ₹1.95 lakh and authorised capital is ₹5 lakh, so about 39% of the authorised amount has been issued.
When did Sphaerapharma last file accounts and hold an AGM?
The last AGM on record was on 26 September 2025, and the latest balance sheet is for the year ending 31 March 2025.
Where can I see charges and lenders for Sphaerapharma?
No charge is open. The one charge registered against Sphaerapharma has been satisfied. Lenders named in the filings include Biotechnology Industry Research Assistance Council.
Have any directors left Sphaerapharma?
Yes, eight former directors are on record. The most recent to leave were Somdutta Sen (October 2021), Jugal Ajit Bhatia (September 2018) and Chandan Kumar (June 2018).
Which companies share directors with Sphaerapharma?
8 companies share directors with Sphaerapharma. Among them are Cyro Healthcare Private Limited, Sphaera Pharma Private Limited, Advantium Infrastructure Private Limited and 5 more.
What is the turnover or revenue of Sphaerapharma?
Based on filed financial statements, the revenue of Sphaerapharma for FY 2023 was in the ₹1–10 Lakh range. That is down 64.8% on the previous year. Exact year-wise revenue, profit and balance sheet figures are on the Financial tab.
What is the net worth of Sphaerapharma?
For FY 2023, the net worth of Sphaerapharma was negative, in the ₹1–5 Cr range.
How can I get the financial details of Sphaerapharma?
The latest accounts on record are for FY 2023. The Financial tab has year-wise profit and loss, balance sheet and ratios, with exact figures after you sign in.
What is the official website of Sphaerapharma?
The website on record for Sphaerapharma is https://sphaerapharma.com.
Which company owns sphaerapharma.com?
sphaerapharma.com is the website listed for Sphaera Pharma Research And Development Private Limited in its company records.
Sphaerapharma - is it listed or unlisted?
Sphaerapharma is unlisted, so its shares are not traded on a stock exchange. Its CIN starts with U for the same reason.
What is the ROC code of Sphaerapharma?
Sphaerapharma is registered with ROC Delhi.
What is the company classification of Sphaerapharma?
MCA classifies Sphaerapharma as: Private Limited Indian Non-Government Company.
Does Sphaerapharma have GST registrations on file?
Yes, one active GST registration is linked to Sphaerapharma.

Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.